Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells.
Akasaka Y, Hasei S, Ohata Y, Kanna M, Nakatsu Y, Sakoda H, Fujishiro M, Kushiyama A, Ono H, Matsubara A, Hinata N, Asano T, Yamamotoya T. Akasaka Y, et al. Among authors: hinata n. Int J Mol Sci. 2023 Nov 6;24(21):16011. doi: 10.3390/ijms242116011. Int J Mol Sci. 2023. PMID: 37958994 Free PMC article.
Long-term efficacy of penile rehabilitation with low-intensity extracorporeal shock wave therapy for sexual and erectile function recovery following robotic-assisted radical prostatectomy: a single-cohort pilot study.
Kohada Y, Babasaki T, Goto K, Inoue S, Kurimura Y, Tasaka R, Takemoto K, Miyamoto S, Kobatake K, Kitano H, Ikeda K, Hieda K, Hayashi T, Hinata N. Kohada Y, et al. Among authors: hinata n. Sex Med. 2023 May 22;11(2):qfad023. doi: 10.1093/sexmed/qfad023. eCollection 2023 Apr. Sex Med. 2023. PMID: 37228769 Free PMC article.
[Gene therapy].
Gotoh A, Shirakawa T, Wada Y, Hinata N, Terao S, Hara I, Arakawa S, Kamidono S, Okada H, Takenaka A, Fujisawa M. Gotoh A, et al. Among authors: hinata n. Hinyokika Kiyo. 2005 Feb;51(2):75-9. Hinyokika Kiyo. 2005. PMID: 15773357 Free article. Review. Japanese.
Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.
Shirakawa T, Terao S, Hinata N, Tanaka K, Takenaka A, Hara I, Sugimura K, Matsuo M, Hamada K, Fuji K, Okegawa T, Higashihara E, Gardner TA, Kao C, Chung LW, Kamidono S, Fujisawa M, Gotoh A. Shirakawa T, et al. Among authors: hinata n. Hum Gene Ther. 2007 Dec;18(12):1225-32. doi: 10.1089/hum.2007.074. Hum Gene Ther. 2007. PMID: 18021019 Clinical Trial.
174 results